Public Employees Retirement System of Ohio Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH

Public Employees Retirement System of Ohio boosted its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 0.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,064 shares of the medical equipment provider’s stock after buying an additional 449 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Zimmer Biomet were worth $6,026,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Garde Capital Inc. acquired a new stake in Zimmer Biomet in the first quarter valued at $29,000. Washington Trust Advisors Inc. acquired a new position in Zimmer Biomet in the first quarter worth about $30,000. Columbia River Financial Group LLC acquired a new position in Zimmer Biomet in the first quarter worth about $30,000. Accent Capital Management LLC bought a new stake in shares of Zimmer Biomet in the 1st quarter valued at approximately $35,000. Finally, Cullen Frost Bankers Inc. lifted its stake in Zimmer Biomet by 1,452.4% during the first quarter. Cullen Frost Bankers Inc. now owns 326 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 305 shares during the last quarter. 88.89% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ZBH shares. Redburn Partners set a $130.00 target price on shares of Zimmer Biomet in a report on Thursday, September 18th. Evercore ISI lowered their price objective on shares of Zimmer Biomet from $102.00 to $96.00 and set an “in-line” rating for the company in a research report on Tuesday, July 8th. Rothschild Redb upgraded shares of Zimmer Biomet to a “strong-buy” rating in a research note on Thursday, September 18th. Raymond James Financial lifted their target price on Zimmer Biomet from $104.00 to $113.00 and gave the company an “outperform” rating in a research note on Friday, August 8th. Finally, Roth Capital reiterated a “buy” rating on shares of Zimmer Biomet in a research report on Thursday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $113.16.

Zimmer Biomet Trading Up 1.2%

Shares of ZBH stock opened at $98.18 on Monday. Zimmer Biomet Holdings, Inc. has a 1 year low of $89.22 and a 1 year high of $114.72. The firm has a market capitalization of $19.45 billion, a PE ratio of 23.89, a price-to-earnings-growth ratio of 2.26 and a beta of 0.68. The stock has a fifty day moving average of $100.58 and a two-hundred day moving average of $99.07. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.96 and a current ratio of 1.87.

Zimmer Biomet (NYSE:ZBH) last issued its quarterly earnings data on Thursday, August 7th. The medical equipment provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. The business had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.06 billion. Zimmer Biomet had a net margin of 10.51% and a return on equity of 12.76%. The company’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.01 earnings per share. Zimmer Biomet has set its FY 2025 guidance at 8.100-8.300 EPS. As a group, research analysts expect that Zimmer Biomet Holdings, Inc. will post 8.22 EPS for the current year.

Zimmer Biomet Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, September 30th. Zimmer Biomet’s dividend payout ratio is currently 23.36%.

Insider Activity

In other news, SVP Lori Winkler sold 1,500 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $104.15, for a total value of $156,225.00. Following the completion of the transaction, the senior vice president directly owned 6,833 shares in the company, valued at $711,656.95. This trade represents a 18.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.70% of the stock is owned by company insiders.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.